NCT04641988View on ClinicalTrials.gov

Cardiac Biomarkers and Mortality in Critically Ill Patients With SARS-CoV-2 (COVID-19)

CompletedOBSERVATIONAL
Enrollment

111

Participants

Timeline

Start Date

February 1, 2020

Primary Completion Date

March 1, 2020

Study Completion Date

June 30, 2020

Conditions
COVID-19
Trial Locations (1)

34295

Uhmontpellier, Montpellier

All Listed Sponsors
lead

University Hospital, Montpellier

OTHER

NCT04641988 - Cardiac Biomarkers and Mortality in Critically Ill Patients With SARS-CoV-2 (COVID-19) | Biotech Hunter | Biotech Hunter